Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by Geeryon Mar 06, 2024 2:30pm
115 Views
Post# 35918678

RE:RE:Why wasn't 90 a "Major Catalyst"?

RE:RE:Why wasn't 90 a "Major Catalyst"?Could the 'major catalyst' currently be happening in the background and something we are not privy to? 

Maybe 90 wasn't to be the major catalyst for share price appreciation. Hitting 90 might have been the catalyst to open up the opportunity to have deeper discussions with other parties. 

As for the share price catalyst, I would think the majority that follow this company are on this board and already have lots of shares.

Just spitballing...and hoping that is the case.  


<< Previous
Bullboard Posts
Next >>